CD14 and asbestosis: As illustrated in Fig. 4a, c, the percentages of circulating PD-L1+ CD14+ monocytes were significantly decreased in the asbestosis (mean 0.541%) and silicosis (mean 0.544%) groups compared to the healthy control group (mean 1.203%, P < 0.01).